Estimation of infant dose and exposure to pethidine and norpethidine via breast milk following patient-controlled epidural pethidine for analgesia post caesarean delivery

International Journal of Obstetric Anesthesia

Volumn 20, Issue 2, 2011, Pages 128-134

  Al Tamimi, Y ^a   Ilett, K F ^b,c   Paech, M J ^c,d   O'Halloran, S J ^b,e   Hartmann, P E ^e  

^a Joondalup Health Campus ^*  (Australia)

^b PATHWEST LABORATORY MEDICINE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d KING EDWARD MEMORIAL HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Breast milk; Caesarean delivery; Neonatal exposure; Norpethidine; Pethidine; Relative infant dose

Indexed keywords

NORPETHIDINE; PETHIDINE;

ARTICLE; BIRTH WEIGHT; BODY WEIGHT; BREAST FEEDING; BREAST MILK; CESAREAN SECTION; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG TISSUE LEVEL; FEMALE; HUMAN; INFANT; MALE; NEUROLOGIC AND ADAPTIVE CAPACITY SCORE; OBSERVATIONAL STUDY; PARITY; PATIENT CONTROLLED ANALGESIA; SCORING SYSTEM;

ANALGESIA, EPIDURAL; ANALGESIA, OBSTETRICAL; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS, OPIOID; BREAST FEEDING; CESAREAN SECTION; FEMALE; HUMANS; INFANT, NEWBORN; MEPERIDINE; MILK, HUMAN; PAIN, POSTOPERATIVE; PREGNANCY;

EID: 79953312222     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2010.12.004     Document Type: Article

References (36)

1. Ngan Kee WD. Epidural pethidine: pharmacology and clinical experience. Anaesth Intensive Care 1998;26:247-55. (Pubitemid 28251915)
2. Tamsen A, Hartvig P, Fagerlund C, Dahlström B. Patient-controlled analgesic therapy. Part I: pharmacokinetics of pethidine in the pre- and postoperative periods. Clin Pharmacokinet 1982;7:149-63.
3. Armstrong PJ, Bersten A. Normeperidine toxicity. Anesth Analg 1986;65:536-8. (Pubitemid 16143312)
4. Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, Reidenberg MM. Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer. Ann Intern Med 1977;86:738-41. (Pubitemid 8118769)
5. Kaiko R, Foley K, Grabinski P et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983;13:180-5. (Pubitemid 13188214)
6. Caldwell J, Notarianni LJ. Disposition of pethidine in childbirth. Br J Anaesth 1978;50:307-8. (Pubitemid 9058532)
7. Pokela ML, Olkkola KT, Koivisto M, Ryhänen P. Pharmacokinetics and pharmacodynamics of intravenous meperidine in neonates and infants. Clin Pharmacol Ther 1992;52:342-9.
8. Caldwell J, Waklie LA, Notariannni LJ et al. Maternal disposition of pethidine in childbirth- a study using quantitative gas chromotography-mass spectrometry. Life Sci 1978;22:589-96. (Pubitemid 8295830)
9. Shnider SM, Moya F. Effects of meperidine on the newborn infant. Am J Obstet Gynecol 1964;89:1009-15.
10. Kuhnert BR, Kuhnert PM, Tu AS, Lin DC. Meperidine and normeperidine levels following meperidine administration during labor. II. Fetus and neonate. Am J Obstet Gynecol 1979;133:909-14. (Pubitemid 9141396)
11. Belfrage P, Boreus LO, Hartvig P, Irestedt L, Raabe N. Neonatal depression after obstetrical analgesia with pethidine: the role of the injection-delivery time interval and of the plasma concentrations of pethidine and norpethidine. Acta Obstet Gynecol Scand 1981;60:43-9. (Pubitemid 11191287)
12. Hodgkinson R, Bhatt M, Wang CN. Double-blind comparison of the neurobehaviour of neonates following the administration of different doses of meperidine to the mother. Can Anaesth Soc J 1978;25:405-11. (Pubitemid 9150458)
13. Belsey EM, Rosenblatt DB, Lieberman BA et al. The influence of maternal analgesia on neonatal behaviour. I. Pethidine. BJOG 1981;88:398-406.
14. Kuhnert BR, Linn PL, Kennard MJ, Kuhnert PM. Effects of low doses of meperidine on neonatal behavior. Anesth Analg 1985;64:335-42. (Pubitemid 15130773)
15. Nissen E, Widstrom AM, Lilja G et al. Effects of routinely given pethidine during labour on infants' developing breastfeeding behaviour: effects of dose-delivery time interval and various concentrations of pethidine/norpethidine in cord plasma. Acta Paediatr 1997;86:201-8. (Pubitemid 27086776)
16. Wittels B, Scott DT, Sinatra RS. Exogenous opioids in human breast milk and acute neonatal neurobehavior: a preliminary study. Anesthesiology 1990;73:864-9. (Pubitemid 20380929)
17. Wittels B, Glosten B, Faure E et al. Postcesarean analgesia with both epidural morphine and intravenous patient-controlled analgesia: neurobehavioral outcomes among nursing neonates. Anesth Analg 1997;85:600-6. (Pubitemid 27381314)
18. Peiker G, Muller B, Ihn W et al. Ausseheidung von pethidin durch die muttermilch. (Excretion of pethidine in mother's milk). Zentralbl Gynakol 1980;102:537-41. (Pubitemid 10073110)
19. Freeborn SF, Calvert RT, Black P et al. Saliva and blood pethidine concentrations in the mother and the newborn baby. Br J Obstet Gynaecol 1980;87:966-9. (Pubitemid 11250492)
20. Quinn PG, Kuhnert BR, Kaine CJ et al. Measurement of meperidine and normeperidine in human breast milk by selected ion monitoring. Biochem Environ Mass Spectrom 1986;13:133-5. (Pubitemid 17190529)
21. Paech MJ, Moore JS, Evans SF. Meperidine for patient-controlled analgesia after cesarean section. Anesthesiology 1994;80:1268-76.
22. Ilett KF, Paech MJ, Page-Sharp M et al. Use of a sparse sampling study design to assess transfer of tramadol and its O-desmethyl metabolite into transitional breast milk. Br J Clin Pharmacol 2008;65:661-6. (Pubitemid 351535096)
23. Banks S, Pavy T. A portable, disposable device for patient-controlled epidural analgesia following Caesarean section: evaluation by patients and nurses. Aust N Z J Obstet Gynaecol 2001;4:372-5. (Pubitemid 33100672)
24. Amiel-Tison C, Barrier G, Shnider SM, Levinson G, Hughes SC, Stefani SJ. A new neurologic and adaptive capacity scoring system for evaluating obstetric medications in full-term newborns. Anesthesiology 1982;56:340-50. (Pubitemid 12104229)
25. Brockhurst NJ, Littleford JA, Halpern SH. The neurologic and adaptive capacity score. A systematic review of its use in obstetric anesthesia research. Anesthesiology 2000;92:237-46.
26. Bennett PN. Use of monographs on drugs. In: Bennett PN, editor. Drugs and Human Lactation. 2nd ed. Amsterdam: Elsevier; 1996. p. 67-74.
27. Jansson L, Choo R, Harrow C et al. Concentrations of methadone in breast milk and plasma in the immediate perinatal period. J Hum Lact 2007;23:184-90. (Pubitemid 46681153)
28. Neville M, Keller R, Seacat J et al. Studies in human lactation: milk volumes in lactating women during the onset of lactation and full lactation. Am J Clin Nutr 1988;48:1375-86. (Pubitemid 19008568)
29. Neville MC, Walsh CT. Effects of drugs on milk secretion and composition. In: Bennett PN, editor. Drugs and Human Lactation. Amsterdam: Elsevier; 1996. p. 15-45.
30. Purcell-Jones G, Dormon F, Sumner E. The use of opioids in neonates. A retrospective study of 933 cases. Anaesthesia 1987;42:1316-20.
31. Siberry GK, Iannone R. Pethidine in the newborn. In: Siberry GK, Iannone R, editors. The Harriet Lane Handbook (A manual for pediatric house officers). 5th ed. Mosby, Harcourt Health Science Company: St. Louis; 1997. p. 764.
32. Yaster M, Deshpande JK. Management of pediatric pain with opioid analgesics. J. Pediatr. 1988;113:421-9.
33. Miall-Allen VM, Whitelaw AG. Effect of pancuronium and pethidine on heart rate and blood pressure in ventilated infants. Arch Dis Child 1987;62:1179-80.
34. Geller R. Meperidine in patient-controlled analgesia: a near-fatal mishap. Anesth Analg 1993;76:655-7. (Pubitemid 23077135)
35. Sjöström S, Hartvig D, Tamsen A. Patient-controlled analgesia with extradural morphine or pethidine. Br J Anaesth 1988;60:358-66'.
36. Halpern SH, Littleford JA, Brockhurst NJ, Youngs PJ, Malik N, Owen HC. The neurologic and adaptive capacity score is not a reliable method of newborn evaluation. Anesthesiology 2001;94:958-62. (Pubitemid 32506121)